Literature DB >> 26614367

Clinical Presentation and Diagnosis of Neuroendocrine Tumors.

Aaron I Vinik1, Celine Chaya2.   

Abstract

Neuroendocrine tumors (NETs) are slow-growing neoplasms capable of storing and secreting different peptides and neuroamines. Some of these substances cause specific symptom complexes, whereas others are silent. They usually have episodic expression, and the diagnosis is often made at a late stage. Although considered rare, the incidence of NETs is increasing. For these reasons, a high index of suspicion is needed. In this article, the different clinical syndromes and the pathophysiology of each tumor as well as the new and emerging biochemical markers and imaging techniques that should be used to facilitate an early diagnosis, follow-up, and prognosis are reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Diagnosis; GEP-NETs; PNETs; Syndromes and their tumors

Mesh:

Substances:

Year:  2015        PMID: 26614367     DOI: 10.1016/j.hoc.2015.08.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  19 in total

1.  Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Curr Probl Surg       Date:  2020-05-15       Impact factor: 1.909

2.  Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.

Authors:  George A Fisher; Edward M Wolin; Nilani Liyanage; Susan Pitman Lowenthal; Beloo Mirakhur; Rodney F Pommier; Montaser Shaheen; Aaron Vinik
Journal:  Oncologist       Date:  2017-10-16

3.  The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.

Authors:  Bo-Hao Zheng; Cheng Zhang; Wen-Ze Wan; Wen-Tao Sun; Xi Cheng; Xiao-Jian Ni; Xiao-Ling Ni; Tao Suo; Han Liu; Sheng Shen; Hou-Bao Liu
Journal:  BMC Surg       Date:  2022-06-29       Impact factor: 2.030

4.  LARGE CELL METASTATIC PANCREATIC NEUROENDOCRINE CARCINOMA TREATED WITH SOMATOSTATIN ANALOGUES - CASE REPORT AND LITERATURE REVIEW.

Authors:  A Croitoru; I Dinu; V Herlea; G Becheanu; M Grasu; I Lupescu; S O Dima; F Buica; T Dumitrascu; C Lungulescu; V M Croitoru; A Tanase; S M Negru; I M Gramaticu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

5.  Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?

Authors:  Yi-Zarn Wang; Aman Chauhan; Robert A Ramirez; David T Beyer; Melissa A Stevens; Eugene A Woltering; J Philip Boudreaux; Lowell Anthony
Journal:  J Gastrointest Oncol       Date:  2019-10

Review 6.  Management of Small Bowel Neuroendocrine Tumors.

Authors:  Aaron T Scott; James R Howe
Journal:  J Oncol Pract       Date:  2018-08       Impact factor: 3.714

7.  Co-expression of Achaete-Scute Homologue-1 and Calcitonin Gene-Related Peptide during NNK-Induced Pulmonary Neuroendocrine Hyperplasia and Carcinogenesis in Hamsters.

Authors:  Xu Naizhen; R Ilona Linnoila; Shioko Kimura
Journal:  J Cancer       Date:  2016-10-23       Impact factor: 4.207

8.  Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States.

Authors:  Monika Wagner; Dima Samaha; Hanane Khoury; William M O'Neil; Louis Lavoie; Liga Bennetts; Danielle Badgley; Sylvie Gabriel; Anthony Berthon; James Dolan; Matthew H Kulke; Mireille Goetghebeur
Journal:  Adv Ther       Date:  2017-12-21       Impact factor: 3.845

Review 9.  Surgical Management of Neuroendocrine Tumor Liver Metastases.

Authors:  Catherine G Tran; Scott K Sherman; Chandrikha Chandrasekharan; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2020-10-20       Impact factor: 3.495

10.  Flushing: A Diagnostic Dilemma.

Authors:  Rekha Ravikumar; Salil Avasthi; Deepti Avasthi
Journal:  Cureus       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.